Charles River Expands Apollo™ Ecosystem with Custom Client Experiences
Charles River Laboratories International, Inc. (NYSE: CRL) today introduced Apollo™ for CRADL®, a secure cloud-based platform designed to enhance its vivarium rental services. This digital platform connects clients effortlessly with the training, tools, and services required to initiate research quickly. Serving as a companion to CRADL’s current rental space offering, Apollo features a centralized dashboard that links clients to online training, Charles River’s Research Models Online Ordering System, and additional study support services.
Charles River Laboratories International, Inc. (NYSE: CRL) has introduced Apollo™ for CRADL®, a cutting-edge, secure cloud-based platform designed to streamline and enhance vivarium rental services for drug discovery and development programs. Mark Mintz, Corporate Senior Vice President and Chief Information Officer at Charles River, highlighted Apollo as the technology backbone driving the company’s digital transformation. “Apollo is the tech stack that is powering Charles River’s digital transformation,” Mintz said. “It’s a high-impact platform, continuously expanding to offer clients greater access to data, products, and services across our portfolio. Apollo enables data-driven decision-making and accelerates operational processes, creating value for clients and driving efficiencies in drug discovery and development.”
Apollo for CRADL simplifies and accelerates the startup of drug discovery and development programs by streamlining client onboarding. This platform significantly speeds up the process of initiating research within CRADL, offering a seamless and efficient solution for clients. Apollo also allows clients direct control over reservations for technical services, rooms, and equipment, all while simplifying protocol management and enhancing communication with Institutional Animal Care and Use Committees (IACUC) to expedite research execution.
Apollo for CRADL is part of a broader series of innovations integrating the Apollo technology stack into Charles River’s extensive portfolio of services. These solutions are designed to optimize research workflows across various stages of drug discovery and development:
- Apollo for CRADL: This service simplifies administrative tasks tied to CRADL’s vivarium rental solutions, freeing clients to focus on starting their research programs more efficiently. By handling reservations and managing communications with committees, Apollo helps researchers begin their work faster, ensuring that more time is dedicated to actual research rather than logistics.
- Apollo for Safety Assessment: This platform empowers clients with real-time data visualization, milestone tracking, document management, and program planning tools, expediting safety assessments and facilitating more timely decision-making in the early stages of drug development.
- Apollo for Biologics: A centralized platform that streamlines sample submission forms, sample tracking, and document exchange, Apollo for Biologics ensures accuracy in handling critical data while saving clients valuable time.
- Apollo for Discovery: Focused on oncology research, Apollo for Discovery offers instant access to oncology study price estimates and facilitates better planning, budgeting, and study purchasing. This allows researchers to make quicker decisions, access expert consultations, and fast-track approvals.
- Apollo for Logica®: This service supports clients by delivering near real-time updates for Logica® AI-powered small molecule programs, providing flexibility and agility to measure success more effectively during development.
- Research Models Online Ordering System: Apollo includes an interactive catalog linked to real-time pricing systems and inventory, enabling clients to view availability and delivery schedules. This system offers a more personalized purchasing experience with immediate order confirmations.
Through the continuous expansion of Apollo’s capabilities, Charles River is enhancing client experiences and driving efficiencies across the entire research and development lifecycle, from discovery to non-clinical development.
About CRADL®
CRADL® (Charles River Accelerator and Development Lab) is a premier resource for clients to launch or expand in vivo drug research programs. CRADL offers flexible vivarium rental solutions integrated with Charles River’s full portfolio of drug discovery and non-clinical development resources. The CRADL vivarium network spans nearly 30 facilities in key biohubs, including Boston, San Francisco Bay, San Diego, Seattle, Philadelphia, Chicago, Thousand Oaks, Shanghai, Chengdu, Suzhou, and London. This global network supports the biotech ecosystem by enabling researchers to quickly advance their science while retaining the flexibility to expand, relocate, or co-locate, all while benefiting from reliable, high-quality in vivo facilities nearby.
About Charles River
Charles River is a global leader providing essential products and services to accelerate the research and drug development efforts of pharmaceutical and biotechnology companies, government agencies, and academic institutions. The company’s dedicated employees work to deliver precisely what clients need to improve and expedite the discovery, early-stage development, and safe manufacturing of new therapies, ultimately helping bring critical treatments to the patients who need them most. Charles River continues to innovate and expand its service offerings, ensuring it remains at the forefront of research and development solutions.
